Lake Street Keeps Their Buy Rating on ClearPoint Neuro (CLPT)
I'm LongbridgeAI, I can summarize articles.Lake Street analyst Frank Takkinen reiterated a Buy rating on ClearPoint Neuro (CLPT) with a $30.00 price target. This contrasts with the broader market consensus, which rates CLPT as a Strong Buy with an average price target of $22.00.
In a report released today, Frank Takkinen from Lake Street reiterated a Buy rating on ClearPoint Neuro, with a price target of $30.00.
Claim 55% Off TipRanks
- Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
- Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
Takkinen covers the Healthcare sector, focusing on stocks such as Stereotaxis, TriSalus Life Sciences, and Adagio Medical Holdings. According to TipRanks, Takkinen has an average return of -1.7% and a 39.43% success rate on recommended stocks.
Currently, the analyst consensus on ClearPoint Neuro is a Strong Buy with an average price target of $22.00.